Larimar Therapeutics (LRMR) Stock Price, Quote, News & History | Benzinga

Larimar Therapeutics Inc (LRMR) Stock Price, Quote, News & History

LRMRNASDAQ

Trade with Public

Trade with Public

$4.10

-0.01-0.24%

At close: Aug 5, 5:00 PM EST

$4.15

0.051.22%

After Hours: 7:53 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$4.11

Close

$4.10

Volume / Avg.

1.28M / 2.15M

Day Range

$4.08 - $4.29

52 Wk Range

2.72 - 6.42

Market Cap

$431.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

16.81%

Days to Cover

4.89

Recent Larimar Therapeutics Inc News

Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug

Larimar Therapeutics Inc (LRMR) submits first module of Biologics License Application for investigational treatment for Friedreich's ataxia, with FDA support and positive long-term data showing durable safety profile and clinical improvements compared to natural history data.

Vandana Singh

Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrollment of first patient in phase 3 trial.

Avi Kapoor

Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announcing acquisition of Best Praise International for $10.75 million.

Avi Kapoor

Nvidia To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts changed outlook on top names. Keybanc, Leerink, Wedbush, DA Davidson, Benchmark, Piper Sandler, Morgan Stanley, Evercore raised price targets.

Avi Kapoor

C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-155.92M

Investing Cash Flow (TTM)

55.11M

Financing Cash Flow (TTM)

172.77M

Free Cash Flow (TTM)

-156.08M

Capital Expenditure (TTM)

-153.00K

Net Change in Cash (TTM)

71.95M

Analyst Trends and Forecast

2

May

1

Jun

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$274.61M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.34

Earnings Yield % (TTM)

-49.02%

Earnings Yield % (FWD)

-39.02%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.23

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$92.69M

Debt to Equity

0.04

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.11

Close

$4.10

Volume / Avg.

1.28M / 2.15M

Day Range

$4.08 - $4.29

52 Wk Range

2.72 - 6.42

Market Cap

$431.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

16.81%

Days to Cover

4.89

About

Sector

Health Care

Industry

Biotechnology

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlab...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Larimar Therapeutics (LRMR) stock?

A

You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Larimar Therapeutics (LRMR) competitors?

A

There are no as such competitors for Larimar Therapeutics.

Q

What is the forecast, or price target, for Larimar Therapeutics (LRMR) stock?

A

Larimar Therapeutics has a consensus price target of $15.58.

Q

What is the current price for Larimar Therapeutics (LRMR)?

A

The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $4.15 last updated August 5, 2026 at 7:53 PM EDT.

Q

Does Larimar Therapeutics (LRMR) pay a dividend?

A

There are no upcoming dividends for Larimar Therapeutics.

Q

When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?

A

Larimar Therapeutics does not have any upcoming earnings scheduled.

Q

Is Larimar Therapeutics (LRMR) going to split?

A

There is no upcoming split for Larimar Therapeutics.

Q

What sector and industry does Larimar Therapeutics (LRMR) operate in?

A

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.